HighLife is a medical device company dedicated to advancing transcatheter solutions for structural heart disease. The company’s TMVR system is designed to provide a transfemoral, durable, and anatomically versatile replacement option for patients with severe mitral regurgitation who are underserved by existing therapies.
Founded in 2010 and headquartered in Paris, HighLife also operates a U.S. facility in Irvine, California, and works in close collaboration with leading physicians and clinical centers worldwide.
Venture Capital
Current
Europe
Financing round
Medical Devices
2026
Status
Creation Date
Investment Date
Fund Name